Neos Therapeutics, Inc. (NEOS:NASDAQ) Annual Reports & Investor Relations Material

Overview

Neos Therapeutics is a pharmaceutical company specializing in the development and production of products for the treatment of central nervous system (CNS) disorders. The company has a portfolio of products including Adzenys XR-ODT, Cotempla XR-ODT, and Adzenys-ER, all of which treat ADHD. In addition, the company is developing NT0502, a treatment for sialorrhea in patients with neurological conditions. Neos Therapeutics is a commercial-stage company listed on the NASDAQ under the ticker symbol NEOS.

Annual Reports

Frequently Asked Questions

What is Neos Therapeutics, Inc.'s ticker?

Neos Therapeutics, Inc.'s ticker is NEOS

What exchange is Neos Therapeutics, Inc. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Neos Therapeutics, Inc.'s headquarters?

They are based in Grand Prairie, Texas

How many employees does Neos Therapeutics, Inc. have?

There are 201-500 employees working at Neos Therapeutics, Inc.

What is Neos Therapeutics, Inc.'s website?

It is https://www.neostx.com/

What type of sector is Neos Therapeutics, Inc.?

Neos Therapeutics, Inc. is in the Healthcare sector

What type of industry is Neos Therapeutics, Inc.?

Neos Therapeutics, Inc. is in the Drug Manufacturers - Other industry

Who are Neos Therapeutics, Inc.'s peers and competitors?

The following five companies are Neos Therapeutics, Inc.'s industry peers:

- Avadel Pharmaceuticals plc

- OptiNose, Inc.

- Harrow Health

- Relmada Therapeutics, Inc.

- Incannex Healthcare Limited